Cookie Img
Send SMS Send Inquiry
Home » Products » Anticancer Drugs » Tamoxifen Citrate Tablet

Tamoxifen Citrate Tablet

Tamoxifen Citrate Tablet
Tamoxifen Citrate Tablet
Product Code : TCT 01
Brand Name : Cytotam Tablet
Product Specifications
  • Drug Type
  • General Medicines
  • Physical Form
  • Tablets
Trade Information
  • Minimum Order Quantity
  • 1
  • Unit of Measure
  • Box/Boxes
  • Payment Terms
  • Cash in Advance (CID), Cheque
  • Supply Ability
  • 1000 Per Week
  • Delivery Time
  • 10 Days
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
Product Description

Tamoxifen Citrate Tablet

 

Our customer-centric approach and sound capabilities enable us to emerge as a reliable organization engaged in offering our clients Tamoxifen Citrate Tablet. This tablet is ideal for treating breast cancer. To comply with set safety norms, we use finest quality compounds to process this tablet. Packed in air tight materials, this Tamoxifen Citrate Tablet is available in different quantity packaging options.

Key Features
  •  Extended shelf life
  •  Free from adulteration
  •  Highly effective
Indications

Cytotam is prescribed by physicians for treating some specific types of Breast Cancer.

Metastatic Breast Cancer

Cytotam is used for treating metastatic breast cancer in both women and men. In women, during premenopausal suffer from metastatic breast cancer. This is also an suitable substitute to oophorectomy or ovarian irradiation. Patient whose tumors are estrogen receptor is positive is likely to get more benefited from tamoxifen citrate therapy.

Reduces in Breast Cancer in High Risk Women

Cytotam is very effective in reducing breast cancer in women who have high risk for breast cancer. In a study done for 5 years this effect has been described with a median follow-up of 4.2 years. Around 25% of patients who participated in this study received this drugs for 5 years. Though all the longer-term effects are not clearly known. But it was clear from this study that there was no effect of tamoxifen on breast cancer-related mortality.

Cytotam is only prescribed for high-risk women which is defined as women at least of 35 years of age with a 5-year predicted risk of breast cancer 1.67%, as calculated by the gail model.

Ductal Carcinoma in Situ (DCIS)


Tmoxifen citrate is prescribed for women suffering from DCIS, breast surgery and radiation. It is effective in reducing the risk of invasive breast cancer. Decision regarding therapies with tamoxifen citrate which are effective in reducing breast cancer incidence are based upon an single person assessment of associated benefits and risks associated with tamoxifen citrate therapy. Data's collected from various clinical trails at present supports adjuvant tamoxifen citrate therapy for patients suffering from breast cancer.

Adjuvant Treatment of Breast Cancer


Cytotam is also prescribed for treating node-positive breast cancer in women. It also includes treatment of axillary dissection, total mastectomy or segmental mastectomy and breast irradiation.
 
Values of Estrogen and progesterone receptor helps in predicting whether adjuvant tamoxifen citrate therapy will be beneficial or not. In addition to this, Cytotam is also effective in reducing the occurrence of contralateral breast cancer with the help of adjuvant tamoxifen citrate therapy for treating breast cancer.



ACTIZA PHARMACEUTICAL

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



We are looking forward to foreign inquiries. 
ACTIZA PHARMACEUTICAL All Rights Reserved.